CASI Pharmaceuticals, Inc.
CASIF
$0.10
$0.00-2.38%
OTC PK
| 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.63M | 4.69M | 12.70M | 12.70M | 16.09M |
| Total Receivables | 4.09M | 2.61M | 7.60M | 7.60M | 15.35M |
| Inventory | 1.60M | 2.61M | 4.15M | 4.15M | 5.25M |
| Prepaid Expenses | 2.14M | 2.01M | 2.71M | 2.71M | 2.89M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.46M | 11.92M | 27.16M | 27.16M | 39.58M |
|
|
|||||
| Total Current Assets | 13.46M | 11.92M | 27.16M | 27.16M | 39.58M |
| Net Property, Plant & Equipment | 9.52M | 9.95M | 10.92M | 10.92M | 11.36M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 221.00K | 224.00K | 233.00K | 233.00K | 238.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 740.00K | 660.00K | 590.00K | 590.00K | 587.00K |
| Total Assets | 25.65M | 24.46M | 40.82M | 40.82M | 53.67M |
|
|
|||||
| Total Accounts Payable | 1.07M | 560.00K | 1.20M | 1.20M | 2.72M |
| Total Accrued Expenses | 13.90M | 20.01M | 14.03M | 14.03M | 8.47M |
| Short-term Debt | 1.00M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 25.04M | 18.86M | 18.49M | 18.49M | 19.61M |
| Total Finance Division Other Current Liabilities | 8.66M | -- | -- | -- | 5.66M |
| Total Other Current Liabilities | 8.66M | -- | -- | -- | 5.66M |
| Total Current Liabilities | 49.67M | 39.42M | 33.71M | 33.71M | 36.45M |
|
|
|||||
| Total Current Liabilities | 49.67M | 39.42M | 33.71M | 33.71M | 36.45M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.00M | -- | -- | -- | -- |
| Capital Leases | 1.44M | -- | -- | -- | 2.54M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.82M | 13.63M | 15.18M | 15.18M | 12.84M |
| Total Liabilities | 62.93M | 53.05M | 48.89M | 48.89M | 51.82M |
|
|
|||||
| Common Stock & APIC | 722.24M | 721.24M | 714.59M | 714.59M | 713.30M |
| Retained Earnings | -748.13M | -735.09M | -710.83M | -710.83M | -700.08M |
| Treasury Stock & Other | -11.39M | -14.74M | -11.83M | -11.83M | -11.38M |
| Total Common Equity | -37.28M | -28.59M | -8.07M | -8.07M | 1.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.28M | -28.59M | -8.07M | -8.07M | 1.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.28M | -28.59M | -8.07M | -8.07M | 1.85M |
|
|
|||||